Godrej Industries Ltd

- Godrej Industries expresses confidence in strong medium to long-term growth, encouraged by GST implementation expected to boost consumption and GDP growth. - Godrej Properties anticipates substantial positive developments, with a robust project pipeline and plans to add partners or fully manage new projects in the coming months. - Godrej Agrovet sees potential in under-penetrated dairy feed markets and is expanding its Triazole portfolio post-Astec acquisition, more than doubling it in the last year. - Animal feed volumes were flat recently; however, certain segments like fish and cattle feed showed growth, while broiler feed declined. Future market share plans are restricted from comment due to DRHP filing. - Chemicals business growth driven by exports is expected to normalize after planned plant shutdowns last year. - The Oleochemicals business plans to improve margins via value-added products over 2-3 years without major capital investments. - Overall, the company emphasizes prudent strategy, agile execution, and long-term profitable growth.

- Godrej Industries expresses confidence in strong medium to long-term growth driven by GST implementation boosting consumption and GDP growth. - Financial highlights show a mixed Q1 FY18 performance but management expects better results in coming quarters. - Godrej Agrovet’s PBT grew by 13% with steady growth in revenues; however, no forward-looking guidance provided due to DRHP filing. - Oleochemicals business aims for margin improvement over 2-3 years via value-added and specialty products. - Chemicals business showed 30% revenue growth but current surge linked to exports and prior year plant shutdown; continuation uncertain. - Godrej Properties had best-ever residential sales and positive cash flow; focus on consolidations and new projects with potential for impact on P&L. - Management refrains from commenting on future projections for animal feed and crop protection segments due to regulatory restrictions.

- Godrej Properties Limited (GPL) recorded a total sales booking of Rs. 1,474 crore for the quarter, representing a strong YoY growth of 281%. - GPL added four new projects with a saleable area of 4.9 million sq. ft., significantly strengthening its development portfolio, especially in the NCR region. - GPL had strong launches across Mumbai, Pune, and NCR, including the Godrej Origins at ‘The Trees’ in Mumbai, which witnessed sales of 130 apartments within the first week. - The deal pipeline for new projects across the country’s leading real estate markets looks robust. - GPL expects substantial positive news on new projects in the year ahead. - For Godrej Agrovet, no specific order book details were mentioned due to restrictions linked to the DRHP filing, limiting future commentary.

- There is no explicit mention of any current or future fundraising through debt or equity in the provided transcript from the Q1 FY18 earnings call. - Management refrained from discussing future plans or forward-looking statements for Godrej Agrovet due to the DRHP (Draft Red Herring Prospectus) filing and SEBI restrictions. - Regarding Godrej Properties, discussions are ongoing about demerger and exploring options such as bringing on partners or selling assets, but no concrete fundraising plans were disclosed. - Nadir Godrej mentioned that the Oleochemicals business is not capital intensive and they are not investing large amounts of capital in FY18 and FY19, implying limited need for new fundraising there. - Overall, the company is focused on cash flow and managing costs but has not announced specific plans for raising new capital.

- The Oleochemicals business is focusing on value-added products and specialty derivatives to improve EBITDA margins over the next 2-3 years (Page 10). - This business (Oleochemicals) is not very capital intensive and does not require large capital investments in FY18 and FY19 (Page 10). - Regarding Godrej Properties' demerger of commercial, hotel, and retail assets, multiple strategic options are being explored including partnerships or outright sales. No finalized investment plans yet; projects like the office building and hotel are at early stages, with hotel expected to break ground in 18+ months (Pages 8-9). - No mention of other immediate or large-scale capex or strategic investments in the transcript due to restrictions from DRHP filing for Godrej Agrovet (Page 10). Overall, capital investments are modest, focused on specialty product development, and strategic real estate options are under evaluation.